XenoPort, Inc. (NASDAQ:XNPT)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.

Results 1 - 20 of 29 : 1 2 Next »

Recs

0
Member Avatar pchop12316 (56.15) Submitted: 3/3/2015 11:51:53 AM : Outperform Start Price: $7.09 XNPT Score: +0.43

price bargain

Recs

1
Member Avatar zzlangerhans (99.82) Submitted: 2/7/2015 6:15:39 AM : Outperform Start Price: $7.21 XNPT Score: -3.56

I hadn't reviewed Xenoport since April when I heard about the stock rising substantially after hours in late December, apparently solely because of a CNBC tweet that the stock was an RBC analyst's sleeper pick for 2015. I immediately shorted a thousand shares because that's an absolutely idiotic reason for a stock to go up, and only updated my database on the stock afterwards. Completely apart from that after hours move, I wasn't that horrified by what I was seeing. Horizant sales are gradually increasing although they still haven't come close to matching SGA costs. Last May the company licensed arbaclofen, a compound I thought was dead, to Reckitt Benckiser for decent compensation. Finally, the company has fumarate analogue XP23829 in midstage development for psoriasis and relapsing MS. A lot of the value here is speculative, but one of the stories of 2014 was takeouts of small pharmas with approved drugs for niche indications. Some of those companies were Chelsea, NuPathe, Cadence, and Avanir. I see some similarities with Horizant and Xenoport.

This is one of those green thumbs that I hope will take on water fast, because I'd love to start a position in Xenoport if the share price is stable under 7 after the company reports earnings on February 19.

Recs

1
Member Avatar NuclearSteve (70.09) Submitted: 11/6/2014 3:38:27 PM : Outperform Start Price: $7.18 XNPT Score: -4.44

I follow the Baker Brothers on biotech because they have an amzing track record and got me into ACAD sub-7 dollars. Via SEC.gov I just saw them increase their stake by 50% in XNPT. That means, I want in.

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 11/15/2013 4:00:18 AM : Outperform Start Price: $5.15 XNPT Score: +20.94

IHS monthly

Recs

0
Member Avatar rknapton (< 20) Submitted: 8/22/2013 5:31:32 PM : Underperform Start Price: $4.63 XNPT Score: -27.29

Short. Crappy company sells stock much more than product.

Recs

0
Member Avatar Wmjack50 (< 20) Submitted: 9/25/2012 10:48:37 AM : Outperform Start Price: $10.99 XNPT Score: -79.07

prodrugs get approval much more quickly than new drugs

Recs

0
Member Avatar RBuskey106 (60.45) Submitted: 4/4/2012 6:03:38 PM : Outperform Start Price: $4.65 XNPT Score: +2.06

Chart play

Recs

2
Member Avatar siri22 (< 20) Submitted: 10/19/2011 3:11:39 PM : Outperform Start Price: $5.37 XNPT Score: -40.89

Below pre approval price?

Recs

0
Member Avatar projectchris (67.50) Submitted: 6/1/2011 9:38:27 AM : Outperform Start Price: $7.77 XNPT Score: -64.74

just tracking

Recs

0
Member Avatar Woopde (< 20) Submitted: 4/8/2011 1:21:56 AM : Outperform Start Price: $9.77 XNPT Score: -84.11

FDA

Recs

0
Member Avatar KimLanners (< 20) Submitted: 4/7/2011 10:46:52 AM : Outperform Start Price: $10.15 XNPT Score: -87.55

biotech comeback us technicals

Recs

0
Member Avatar franktejon (< 20) Submitted: 7/7/2010 10:25:48 PM : Outperform Start Price: $6.56 XNPT Score: -87.98

strong buy

Recs

0
Member Avatar syazic (56.27) Submitted: 2/26/2010 9:37:08 AM : Outperform Start Price: $8.40 XNPT Score: -105.03

XNPT oversold by shorties.. Intrinsic value is $10-18.

Recs

0
Member Avatar LegitCompute (< 20) Submitted: 2/24/2010 4:03:29 AM : Outperform Start Price: $8.09 XNPT Score: -102.66

This stock is likely to sky rocket from its current price of $8.16 within the next few weeks possibly a couple months. The reason behind this is because they just had a better than expected earnings report, and they have the funds to fund their future research. They also just need to revise their new restless leg drug to be able to get it approved by the FDA. This is definitely a bargain stock at the moment, and soon to be a very profitable stock.

Recs

0
Member Avatar TraderAsh123 (< 20) Submitted: 2/23/2010 11:19:27 PM : Outperform Start Price: $8.22 XNPT Score: -104.24

fill the gap

Recs

2
Member Avatar PapiShasho (< 20) Submitted: 2/19/2010 1:30:30 PM : Outperform Start Price: $7.32 XNPT Score: -91.60

oversold

Recs

0
Member Avatar hansjang (< 20) Submitted: 2/19/2010 7:48:26 AM : Outperform Start Price: $6.82 XNPT Score: -85.69

It should be wait what FDA say for this REJECT.
And, we can do something for this company.
I am waiting for a while.
I believe what XNPT did well.

Recs

1
Member Avatar BuffetsMentor (< 20) Submitted: 2/18/2010 1:47:33 PM : Outperform Start Price: $6.66 XNPT Score: -83.35

bizzounce

Recs

0
Member Avatar riegonla (42.41) Submitted: 2/9/2010 9:53:06 PM : Outperform Start Price: $18.85 XNPT Score: -158.45

25US$ Feb 2011

Recs

1
Member Avatar tenmiles (99.25) Submitted: 1/28/2010 10:26:36 AM : Outperform Start Price: $18.92 XNPT Score: -155.04

Getting restless for a long - playing an anticipated FDA pop in February. Long at $18.82

Results 1 - 20 of 29 : 1 2 Next »

Featured Broker Partners


Advertisement